PRKAA2 and pulmonary fibrosis: Metformin, an activator of AMP-activated protein kinase α (AMPKα; also known as PRKAA) and an inhibitor of lipid synthesis, accelerated the resolution of bleomycin-induced lung fibrosis in mice (Rangarajan et al., 2018).